Chinese: Ban Xia Xie Xin Tang
English: Pinellia Decoction to Drain the Epigastrium
Source: Shanghanlun (Treatise on Cold Damage Diseases)
Pulse: bowstring, rapid
Tongue: thin, yellow, greasy fur
Abdomen: Shinkahiko
Indications: This herbal formula has been used for patients with following health conditions and symptoms:
- Indigestion
- Blenching
- Diarrhea
- Poor appetite
- Flatulence
- Abdominal pain
- Nausea
- Vomiting
- Heart burn
- Bloating
- Hangover
There are many other health conditions that may respond well to this herbal formula, in particular patients exhibiting indicative traditional diagnostic signs and symptoms.
Herbs in This Formula
- Hange (Pinelliae Rhizoma) 5g
- Ogon (Scutellariae Radix) 3g
- Oren (Coptidis Rhizoma) 1g
- Ninjin (Ginseng Radix), 3g
- Kankyo (Zingiberis Siccatum Rhizoma) 2g
- Kanzo (Glycyrrhizae Radix), 3g
- Taiso (Jujubae Fructus) 3g
Note: Suggested dosages of each herb in Kampo formulas are often smaller than those of Traditional Chinese Medicine (TCM). Individual dosages of herbs may be adjusted depending on each patient’s condition, constitutional patterns, quality of the herbs, and other factors involved.
Abdominal pattern (fukusho) of Hangeshashinto (from Fukusho Kiran Yoku ,1809)
Basic and Clinical Research on Hangeshashinto – Updated on Mar 30, 2011
Kawashima, K., Fujimura, Y., Makino, T. & Kano, Y. Pharmacological properties of traditional medicine (XXXII): protective effects of hangeshashinto and the combinations of its major constituents on gastric lesions in rats. Biological & pharmaceutical bulletin 29, 1973-1975 (2006).
Mori K, Kondo T, Kamiyama Y, et al. Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology 51: 403-6 (2003).
Naito T, Itoh H, Yasunaga F, et al. Hange-shashin-to raises levels of somatostatin, motilin, and gastrin in the plasma of healthy subjects. Biological & Pharmaceutical Bulletin 25: 327-31 (2002).
Mori K. Hangeshashin-to (Kampo medicined) in the prevention of irinotecan-induced diarrhea in advanced non-small cell lung cancer. Progress in Medicine 19: 886-90 (1999).
Ohta Y, Nishioka M, Yamamoto Y, et al. Multicenter clinical evaluation of Kampo preparations for medical use in the treatment of gastritis (acute gastritis and acute exacerbation of chronic gastritis) – comparison with gefarnate as a control. Shindan to Chiryo (Diagnosis and Treatment) 78: 2935-46 (1990).